CURE ETF returns, drawdowns and dividends
Direxion Daily Healthcare Bull 3X ETF · Leveraged or inverse ETF
Chart shows price change, dividends not included · Prices through the close of · Updated after every US trading day · Source: Yahoo Finance
CURE returns by period
Total return assumes every dividend is reinvested at the closing price on its ex-dividend date. Price return is the change in the closing price alone. The 3 and 5 year rows also show the yearly rate (CAGR).
| Period | Since | Total return | Price return |
|---|---|---|---|
| 1 month | +32.40% | +32.40% | |
| 3 months | +36.84% | +36.52% | |
| 6 months | +113.73% | +112.43% | |
| Year to date | +60.69% | +59.21% | |
| 1 year | +72.72% | +70.68% | |
| 3 years | +125.65% (+31.12%/yr) | +117.29% (+29.48%/yr) | |
| 5 years | +69.47% (+10.42%/yr) | +59.94% (+9.22%/yr) |
CURE returns by calendar year
| Year | Total return | Price return |
|---|---|---|
| 2026 (to Nov 11) | +60.69% | +59.21% |
| 2025 | +22.55% | +20.88% |
| 2024 | -8.48% | -9.29% |
| 2023 | -9.43% | -11.35% |
| 2022 | -20.51% | -20.85% |
CURE drawdowns and recovery
Max drawdown is the largest fall from a previous peak close to a later close within the period. The deepest fall in the stored history was 54.20%, from $147.52 on April 8, 2022 to $67.57 on Aug. 7, 2025; the price was back at its earlier peak on Aug. 19, 2026, 377 days after the low.
| Measure | Value |
|---|---|
| Max drawdown, 1 year | 31.32% |
| Max drawdown, 3 years | 52.45% |
| Max drawdown, 5 years | 54.20% |
| 52-week closing high | $180.62 Nov. 4, 2026 |
| 52-week closing low | $83.61 May 11, 2026 |
| Latest close | $177.61 Nov. 11, 2026 |
CURE dividends
CURE paid $1.26 per share in the last 12 months over 4 payments, a trailing yield of 0.71% at the latest close. The most recent ex-dividend date was Sept. 22, 2026 ($0.32 per share). Trailing yield is historical, not a forecast or an SEC 30-day yield.
| Year | Dividends per share | Payments |
|---|---|---|
| 2026 (so far) | $0.97 | 3 |
| 2025 | $1.25 | 4 |
| 2024 | $1.08 | 4 |
| 2023 | $2.05 | 4 |
| 2022 | $0.44 | 4 |
Compare CURE with
- TQQQ +8.95%
- SOXL +58.03%
- MULL +366.08%
- MUU +389.08%
- DLLL +280.57%
- AMDL +178.15%
- NRGU +157.26%
- AMUU +183.16%
- AMDG +175.93%
- UCO +133.30%
1-year return, total where available. Add any of them to the CURE chart, rank every ETF in the return explorer, or browse all ETF pages.
About these numbers
- Calculated by FindETFStock from daily closing prices and ex-dividend amounts reported by Yahoo Finance, starting July 16, 2021.
- Total assets are the fund's net assets as reported by Yahoo Finance; for a fund with several share classes, such as Vanguard's, the figure covers the whole fund. Trading volume is the 3-month average of shares traded per day, times the latest price.
- "5 years" is measured from the first stored close, about five years back; a fund or stock with a shorter history shows "Since first close" instead.
- Returns are before taxes and assume dividends are reinvested at the ex-date close with no costs.
- Past performance does not predict future results. This is not investment advice; see the financial disclaimer and methodology.